SynthesisESMO open2022

Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis.

M A Siciliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.